InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Explore the complete record of transactions filed by THERO JOHN F, Chief Executive Officer. Director active across 2 companies, notably Amarin CORP Plc\uk. In total, 7 filings have been published. Total volume traded: €19k. The latest transaction was disclosed on 10 May 2022 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations7 total
€18,98810,000 shares@ €1.8988100.0% of flow
Common Stock
SEC:0001209191-22-028578:0·
Ideal exit: 4 Feb 2023 (T+270)
6,736 shares
Ordinary Shares
SEC:0001562180-21-005143·
6,736 shares
Ordinary Shares
SEC:0001562180-21-005143:0·
6,736 shares
Ordinary Shares
SEC:0001562180-21-004737·
6,736 shares
Ordinary Shares
SEC:0001562180-21-004737:0·
6,736 shares
Ordinary Shares
SEC:0001562180-21-003848·
6,736 shares
Ordinary Shares
SEC:0001562180-21-003848:0·
7 of 7 declarations
About THERO JOHN F
John F. Thero is the President and CEO of Amarin Corp PLC and Cyteir Therapeutics, Inc. He is responsible for the strategic direction and management of operations for both companies. His experience in the biopharmaceutical sector is essential for guiding Amarin and Cyteir towards growth and innovation.
